Type:Notice
Citation:90 FR 12367
Reading Time:about a minute or two
Fisher Clinical Services, Inc. has applied to the Drug Enforcement Administration (DEA) to register as an importer of certain controlled substances. The company intends to import these substances solely for clinical trials. Other types of uses or commercial sales are not allowed under this registration. Interested parties can submit comments or objections electronically by April 16, 2025, and can also request a hearing on the application by the same date.
Simple Explanation
Fisher Clinical Services, Inc. wants permission to bring in special medicines from other countries to test them in studies. People can tell the government what they think about this by April 16, 2025, or ask to have a meeting about it.